Perkembangan Vaksin COVID-19 Produksi Dalam Negeri
Pengembangan vaksin COVID-19 produksi dalam negeri melalui kerja sama dengan BUMN maupun perusahaan swasta terus berjalan, dan diharapkan dapat diedarkan dan digunakan pada 2022.
| ABX | ||
| 2,490.486 | ||
| -218.3100 | -0.0806% | |
| BISNIS-27 | ||
| 334.236 | ||
| -18.3570 | -0.0521% | |
| DBX | ||
| 2,390.163 | ||
| -91.5360 | -0.0369% | |
| ECONOMIC30 | ||
| 66.399 | ||
| -3.9000 | -0.0555% | |
| ESGQKEHATI | ||
| 83.990 | ||
| -4.2710 | -0.0484% | |
| ESGSKEHATI | ||
| 84.254 | ||
| -4.3220 | -0.0488% | |
| I-GRADE | ||
| 117.657 | ||
| -6.8980 | -0.0554% | |
| AUDRP | ||
| 12,589.420 | ||
| 75.6400 | 0.6045% | |
| EURRP | ||
| 20,248.060 | ||
| -4.8100 | -0.0237% | |
| JPYRP | ||
| 114.236 | ||
| 0.1863 | 0.1633% | |
| SINRP | ||
| 14,102.880 | ||
| 20.6700 | 0.1468% | |
| USDRP | ||
| 18,039.000 | ||
| 18.0000 | 0.0999% | |
